Publisert 06.03.2019

Filing of new US provisional patent application

Filing of new US provisional patent application

Regenics has filed a new U.S. Provisional Patent Application No. 62/808,975; on 22-Feb-2019

Entitled: USE OF CELLULAR EXTRACTS FOR SKIN REJUVENATION

Inventors: Gry Kalstad Lønne and Henrik Lund

 The DUE DATE: March 22, 2019 —Assignment (flexible due date)DUE DATE: February 22, 2020—Provisional Conversion and Foreign Filing Deadline

 
 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.